Seven Eight Capital, LP Incyte Corp Transaction History

Seven Eight Capital, LP

$1.05 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$51.18 - $63.75 $919,653 - $1.15 Million	-17,969 Reduced 83.72%	3,493 $211,000
Q1 2024 May 13, 2024	SELL	$56.55 - $66.59 $2.27 Million - $2.67 Million	-40,082 Reduced 65.13%	21,462 $1.22 Million
Q4 2023 Feb 13, 2024	BUY	$52.16 - $64.19 $3.21 Million - $3.95 Million	61,544 New	61,544 $3.86 Million
Q2 2023 Aug 14, 2023	BUY	$60.95 - $75.51 $6.18 Million - $7.65 Million	101,377 New	101,377 $6.31 Million
Q3 2022 Nov 10, 2022	BUY	$66.18 - $82.86 $1.14 Million - $1.43 Million	17,253 New	17,253 $1.15 Million
Q2 2022 Aug 04, 2022	SELL	$66.18 - $83.18 $1.17 Million - $1.46 Million	-17,611 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$66.02 - $79.71 $569,026 - $687,020	8,619 Added 95.85%	17,611 $1.4 Million
Q4 2021 Feb 14, 2022	SELL	$63.34 - $74.11 $1.37 Million - $1.61 Million	-21,706 Reduced 70.71%	8,992 $660,000
Q3 2021 Nov 15, 2021	BUY	$68.67 - $84.02 $2.11 Million - $2.58 Million	30,698 New	30,698 $2.11 Million
Q4 2020 Feb 09, 2021	SELL	$80.74 - $97.7 $895,891 - $1.08 Million	-11,096 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$85.07 - $109.69 $943,936 - $1.22 Million	11,096 New	11,096 $996,000
Q1 2020 May 14, 2020	SELL	$63.18 - $85.97 $2.17 Million - $2.95 Million	-34,275 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$73.04 - $95.72 $554,592 - $726,801	7,593 Added 28.46%	34,275 $2.99 Million
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $1.94 Million - $2.31 Million	26,682 New	26,682 $1.98 Million
Q2 2019 Aug 12, 2019	SELL	$73.52 - $88.7 $559,707 - $675,273	-7,613 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$63.56 - $88.17 $1.03 Million - $1.43 Million	-16,210 Reduced 68.04%	7,613 $655,000
Q4 2018 Feb 14, 2019	BUY	$58.5 - $69.94 $1.22 Million - $1.46 Million	20,900 Added 715.02%	23,823 $1.52 Million
Q3 2018 Oct 18, 2018	BUY	$61.75 - $74.23 $180,495 - $216,974	2,923 New	2,923 $202,000
Q1 2018 May 14, 2018	SELL	$83.06 - $100.98 $766,062 - $931,338	-9,223 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$93.56 - $116.6 $2.01 Million - $2.51 Million	-21,500 Reduced 69.98%	9,223 $874,000
Q3 2017 Oct 16, 2017	BUY	$109.15 - $138.27 $3.24 Million - $4.11 Million	29,700 Added 2903.23%	30,723 $3.59 Million
Q2 2017 Aug 10, 2017	BUY	N/A	1,023	1,023 $129,000

Others Institutions Holding INCY

# of Institutions

645

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.3B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.

Account